<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Tue, 20 Jan 2026 11:05:23 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>NVIDIA and Lilly put $1B behind AI as core drug infrastructure</title><link>https://www.2minutemedicine.com/nvidia-and-lilly-put-1b-behind-ai-as-core-drug-infrastructure/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/12/50_mg_Tramadol_HCl_tablets_generic_Ultram_marketed_by_Amneal_Pharmaceuticals_rotated-300x150.jpg</image_url><description>1. NVIDIA and Eli Lilly plan to invest up to $1B over five years in a joint AI lab to tighten the loop between model building and wet lab validation. ...</description><pubDate>Tue, 20 Jan 2026 13:10:20 GMT</pubDate></item><item><title>Berberine is safe and effective in lowering lipoprotein cholesterol levels in metabolic dysfunction-associated steatotic liver disease</title><link>https://www.2minutemedicine.com/berberine-is-safe-and-effective-in-lowering-lipoprotein-cholesterol-levels-in-metabolic-dysfunction-associated-steatotic-liver-disease/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/11/Liversteatosis_edited-300x150.png</image_url><description>1. In diabetes-free individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) and obesity, berberine is safe, well-tolerated, ...</description><pubDate>Tue, 20 Jan 2026 00:00:00 GMT</pubDate></item><item><title>Lyme disease is associated with significant health care costs</title><link>https://www.2minutemedicine.com/lyme-disease-is-associated-with-significant-health-care-costs/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2016/04/18132_lores-300x150.jpg</image_url><description>1. Lyme disease (LD) is associated with substantial health care costs, with per-patient direct costs consistently high across several analytic methods...</description><pubDate>Mon, 19 Jan 2026 16:00:47 GMT</pubDate></item><item><title>2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]</title><link>https://www.2minutemedicine.com/2mm-ai-roundup-lilly-and-nvidias-1b-ai-lab-illuminas-billion-cell-atlas-astrazenecas-modella-deal-and-claude-for-healthcare-jan-19th-2026/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-300x170.png</image_url><description>NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January 2026, NVIDIA and Eli Eli ...</description><pubDate>Mon, 19 Jan 2026 13:45:25 GMT</pubDate></item><item><title>2 Minute Medicine Rewind January 19, 2026</title><link>https://www.2minutemedicine.com/2-minute-medicine-rewind-january-19-2026/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2017/05/DVT2_cc_wiki_JamesHeilmanMD_edited-300x150.jpg</image_url><description>Electronic Intervention for Patient-Managed Benzodiazepine Tapering 1. An electronic intervention promoting self-management of benzodiazepine cessatio...</description><pubDate>Mon, 19 Jan 2026 11:00:51 GMT</pubDate></item></channel></rss>